THE POTENTIAL ATTRACTIVENESS of measurement of coronary flow reserve in an area ofmyocardium supplied by a stenosed coronary artery has long been recognized. As options for quantifying flow reserve in man have improved, there has been increasing interest in the use of flow reserve measurements to make individual patient care decisions as well as to define pathophysiology in patient groups. The requirements for effective use in individual patients are in many ways more stringent than in patient groups. Factors that must be considered on an individual rather than group basis include effects of variables potentially affecting flow reserve independently of degree of stenosis, theoretical and practical limitations of specific measurement techniques, and confidence limits for procedurally satisfactory measurements.
Factors underlying interest in measurements of flow reserve in man
Limitations of arteriographic estimates of stenosis severity.
Despite the acknowledged pivotal role of coronary arteriography in management decisions in patients with coronary heart disease, the functional significance of an arteriographic lesion often cannot be settled from the arteriogram alone. This point has been emphasized by a number of experimental studies of stenosis behavior, particularly those of Gould.1 It is generally agreed that limitations of arteriographic measurements are most troublesome for stenoses ofmoderate-to-severe degree, i.e., 50% to 90% diameter narrowing. Because of the complex nonlinear relationship between pressure gradient across a stenosis and flow through the stenosis, the effective resistance of a stenotic lesion varies markedly with small changes in degree of stenosis once luminal diameter has been reduced by -70%. For example, at a fixed level of flow, the pressure gradient across a concentric stenosis narrowing luminal diameter by 70% can double as the degree of diameter narrowing increases to 80%, and double again as the degree of narrowing rises from 80% to 90%. Changes in degree of stenosis of this magnitude can result from a number of dynamic as well as static factors and are within the limits of interindividual and intraindividual variation in the estimation of degree of stenosis. In addition, because the transstenotic pressure gradient rises nonlinearly with flow, the effective resistance of even a rigid stenosis increases with increases in myocardial metabolic demand (and therefore flow requirement). "Quantitative" arteriographic approaches have been examined by several laboratories in an effort to deal with limitations of usual clinical estimates of percent diameter narrowing. Measurements of luminal crosssectional area at the point of maximum narrowing are theoretically attractive in terms of dealing with nonconcentric lesion geometry. Absolute area measurements (mm2) avoid the pitfalls of both a single diameter measurement and an expression of percent narrowing in relation to an adjacent area of coronary artery (which is itself involved in the atherosclerotic process). However, the interpretation of an absolute value ofminimum cross-sectional area is hampered by uncertainty concerning the area expected at the same point in the same artery in the absence of stenosis. In a normal coronary artery, luminal cross-sectional area decreases progressively with vessel size as one moves over the epicardial surface from base to apex. In addition, the cross-sectional area of even a single portion of a single vessel, e.g., the left anterior descending artery midway between the base and apex, varies with different patterns of coronary arterial arborization and probably also with sex, body size, ventricular hypertrophy, and other factors.
Because of this problem, "quantitative" area measurements are now sometimes reported in terms of percent reduction in luminal cross-sectional area rather than in absolute values. The measurement of percent reduction in area rather than diameter does minimize errors in the evaluation of nonconcentric lesions, but again uses an adjacent segment of a diseased artery as a "normal reference." The practical utility of either area or diameter estimates of percent narrowing may in part reflect the fact that atherosclerotic lesions often develop in an outward as well as inward direction, i.e., when the lumen of a diseased area of artery adjacent to a lesion is used as the denominator in the calculation of percent stenosis, the error is less than would have occurred if arterial diameter had not increased.
Although these limitations of coronary arteriography need to be recognized, they should be considered in the context of the unique and continuing contributions of arteriography to both patient care and pathophysiology. The "test of time?' is in many ways the ultimate one for a diagnostic or therapeutic technique, and none of the procedures discussed in this review has yet been "tempered" by similarly detailed scrutiny and widespread application over an extended period of time. The current interest in flow reserve recognizes the advantages of combining functional with anatomic information but does not diminish the need for, or value of, the latter.
Compensatory effects ofvasodilation. The ultimate effect of a coronary stenosis depends on the degree to which the increased impedance to flow caused by the stenosis is compensated for by "reserve" vasodilation available at the arteriolar level. The quantitative magnitude of vasodilator flow reserve varies inversely with degree of stenosis as the severity of a stenosis increases. It is useful to think of flow reserve in terms of autoregulation, i.e., the ability of the coronary circulation to maintain flow at a constant level in the face of a decrease in coronary pressure at constant myocardial metabolic demand (figure 1). Flow reserve decreases as coronary pressure falls and becomes exhausted when coronary pressure reaches the point at which autoregulatory vasodilation is maximal.
Although the conceptual attractiveness of the evaluation of stenosis severity by quantitation of flow reserve has long been recognized, techniques potentially applicable to individual coronary arteries in man have only recently become available. The studies of the Iowa group using an epicardial Doppler velocity probe have established that coronary flow reserve is normally as great in man as in experimental animals such as the dog, i.e., fiveto sixfold at usual levels of aortic pressure. 3 In retrospect, earlier human measurements reporting lower levels were probably compromised by the use of less-than-maximum vasodilator stimuli and/or flow measurement techniques that become inadequate at high levels of flow. points represent the transstenotic aortic-coronary pressure gradients for lesions of different severity (here expressed as percent diameter narrowing). As described above, the relationship between transstenotic pressure gradient and percent diameter narrowing is nonlinear, with progressively more rapid increases in gradient as the degree of stenosis exceeds 70%. Autoregulatory reserve is shown as being exhausted between 85% and 90% stenosis, with flow reduced slightly under basal conditions for a 90% diameter stenosis. The stenosis isopleths schematically represent the paths followed by individual stenoses when flow is increased by local vasodilation. Their intersections with the pressure-flow relationship for maximum vasodilation define the reciprocal variation of flow reserve with stenosis severity and demonstrate the attractiveness of the basic concept of the use of flow reserve measurements to define stenosis severity. In specific clinical situations, the situation is more complex than often appreciated. Even assuming a methodologically perfect measurement technique, the value of flow reserve measured in a given artery at a given point in time depends on variables not always considered. These variables can be considered in terms of their effects on (1) coronary pressure, (2) the flow level before vasodilation, and (3) the position of the pressure-flow relationship during maximum vasodilation:
(1) Because of the steepness of the pressure-flow relationship during maximum vasodilation, modest changes in aortic pressure can, by themselves, result in significant changes in flow during maximum vasodilation in even a normal artery, i.e., the large solid triangle in figure 2 moves up or down the pressure-flow relationship for maximum vasodilation. Likewise, in a diseased artery, small dynamic changes in stenosis severity, e.g., active vasoconstriction from 80% to 85% diameter narrowing or a passive reduction in diameter of the same magnitude as intraluminal pressure falls during vasodilation, can change measured reserve to a substantial extent. Wilson et al. 7 have indicated that intracoronary papaverine occasionally produces an increase in stenosis resistance compatible with a passive "collapse" in the area of the lesion (see their figure 8 ).
(2) The level of flow before vasodilation, i.e., the denominator of the flow reserve calculation, varies with metabolic demand. It can also be increased above basal values following recent ischemia, a fact that may be important in measurements made shortly after coronary angioplasty. An increase in resting flow will reduce the measured flow reserve ratio in the absence of a change in flow during maximum vasodilation. As discussed subsequently, the measurement techniques now used most commonly are not able to distinguish between an elevation in prevasodilation flow and a reduction in flow during vasodilation as causes of a reduction in measured flow reserve.
(3) Perhaps most importantly, the pressure-flow relationship during maximum vasodilation can vary substantially on either an acute or chronic basis. Chronic reductions in maximum flow during vasodilation, with corresponding reductions in calculated flow reserve, have been documented in a number of forms of hypertrophy. The shift to the right of the pressure-flow relationship illustrated in figure 2 corresponds to a reduction in flow reserve from 5.0 (large solid triangle) to 3.0 (large solid square) at a normal coronary artery pressure. Reductions of this magnitude have been reported in patients with normal coronary arteries and a 30% increase in left ventricular mass due to essential hypertension; reductions of similar and even greater magnitude have been found in patients with hypertrophy related to valvular and congenital abnormalities.8
In patients with coronary disease, variations in flow reserve for any given degree of stenosis might be expected solely on the basis of the frequent occurrence and variable degree of left ventricular hypertrophy. For example, in figure 2, flow reserve would be essentially the same for an 80% stenosis supplying a normal ventricle and a 50% stenosis supplying a ventricle operating on the shifted pressure-flow relationship for maximum vasodilation.
In any given ventricle, the pressure-flow relationship during maximum vasodilation can vary substantially with changes in hemodynamic factors such as heart rate, contractility, preload, and viscosity. Systematic measurements of coronary reserve during changes in these variables are not yet available in man. However, data from studies in canine hearts illustrate that such changes are potentially important. For example, our laboratory9 found that left ventricular diastolic flow during maximum vasodilation at a coronary pressure of 65 mm Hg was reduced by 30% when ventricular cavity pressure was increased from less than 10 to 20 to 25 mm Hg (see figure 7 in ref. 9) . At a coronary pressure of 30 mm Hg (as might correspond to an -85% stenosis), the same reduction in maximum diastolic flow required an elevation in ventricular cavity pressure to only 15 mm Hg.
Tachycardia affects flow reserve by increasing myocardial metabolic demand (and therefore the prevasodilation flow level) as well as by reducing diastolic time per minute (and therefore shifting the pressure-flow relationship during maximum vasodilation). Tachycardia also illustrates the potential importance of transmural variations in flow reserve, which are difficult to define with any technique presently used in man. Because the compressive effects of systolic contraction decrease progressively across the myocardial wall, tachycardia-induced shifts in the pressure-flow relationship for maximum vasodilation also vary transmurally, and are greatest in the subendocardium. In conscious dogs, Bache and Cobbl' found flow reserve for the full-thickness left ventricular wall to decrease by 32% when the paced ventricular rate was increased from 100 to 150 beats/min. The 32% overall decrease included a 45% reduction in flow reserve in the inner fourth of the ventricle, as contrasted with a 25% reduction in the outer fourth. In addition, while flow reserve in the inner layer was 92% of that in the outer layer at a rate of 100 beats/min, it was only 70% of that in the outer layer at a rate of 150 beats/min. Since transmural differences in flow during maximum vasodilation are often accentuated by coronary stenoses, transmural differences in flow reserve during tachycardia might be a clinically useful variable if they could be measured.
Additional issues that can be mentioned only briefly include collateral flow and possible differences in the degree of vasodilation induced by ischemia and a pharmacologic agent. Measurements of flow in a single coronary artery obviously fail to take into account collateral flow entering the arterial bed distal to the point of flow measurement. It seems likely that the proportional contribution of collateral flow to total myocardial flow would differ before and during pharmacologic vasodilation. With regard to pharmacologic vs ischemic vasodilation, a number of laboratories have now observed vasodilation (in all ventricular layers) in response to adenosine in the setting of reductions in flow sufficient to produce regional myocardial ischemia. Likewise, adrenergic constrictor influences seem able to limit flow increases during exercise as well as ischemia. Although the relevance of these observations for man remains to be clarified, they too potentially confound the interpretation of values of flow reserve measured using pharmacologic vasodilation. invasive, the Doppler technique has the advantage of arterial selectivity and has been validated more extensively than any other now in use. Experience with more than 200 patients in the cardiac catheterization laboratory has recently been summarized. 1'
The Doppler technique's inability to appreciate differences in the prevasodilation flow level before and after an intervention may be an important limitation in attempts to assess changes in flow reserve after angioplasty. Since changes in volume flow related to changes in arterial cross-sectional area are not reflected in measurements of flow velocity, there is also concern about changes in luminal diameter at the probe site between measurements before and during vasodilation. These are often minimized by administration of nitroglycerin before the "prevasodilation" measurement. Catheter position in the coronary artery must not be allowed to change between prevasodilation and vasodilation measurements. The technique's developers use a siderather than end-mounted piezoelectric crystal to minimize the chance that the velocity sampling window includes nonrepresentative velocity patterns near the arterial wall or probe itself. Although the cross-sectional area of the probe is only 0.8 to 1.0 mm2, the guiding catheter through which it is introduced can sometimes limit inflow during maximum vasodilation. To avoid studies in individuals disposed to catheterinduced spasm, ergonovine provocative tests are sometimes performed before probe insertion. Since most flow measurements are performed in relatively proximal arterial branches, effects of collateral flow are an important issue.
An important recent study of the Iowa group in the catheterization laboratory7 was confined to patients with single discrete stenoses in one or two vessels. To minimize effects of variables known to affect flow reserve independently of stenosis severity, individuals with previous myocardial infarction, left ventricular hypertrophy (by echocardiogram or cine computed tomography), left ventricular dysfunction, or angiographically apparent collateral circulation were also excluded. Orthogonal views (600 left anterior oblique, 300 right anterior oblique) were obtained for each lesion. Flow velocity was measured in the stenotic artery before and during the intracoronary infusion of papaverine. Three findings are of interest:
(1) Correlation coefficients for the relationship between measured flow reserve and degree of stenosis were as good for maximum percent diameter narrowing (.82) as for percent area reduction (.85) and absolute minimum cross-sectional area (.79).
(2) Lesions narrowing diameter by no more than 50%, or area by no more than 70%, all showed a normal flow reserve, i.e., greater than 3.5. Lesions narrowing diameter by more than 60%, or area by more than 80%, all showed a reduced flow reserve, i.e., less than 3.5. Values of flow reserve in the 50% to 60% diameter and 70% to 80% area ranges overlapped the normal-abnormal "cut point" of 3.5.
(3) Despite these group separations, there was substantial scatter of individual values of flow reserve at any level of stenosis (particularly when absolute values of area were used to define stenosis severity) (see figures 1, 4, and 6 of ref. 7) . Flow reserve varied from 1.1 to 2.2 for 80% to 90% diameter narrowing, from 1.1 to 2.5 for 70% to 80% diameter narrowing, and from 2.0 to 5.0 for 50% to 60% narrowing. Similarly, flow reserve varied from 1.0 to 2.5 for area stenoses greater than 80%, and from 3.2 to 5.8 for 60% to 80% area stenoses.
Although sizable, the scatter in values of flow reserve in the study cited above was less than in an earlier operating room study of proximal anterior descending stenoses in patients with two-and threevessel disease. 12 These patients were also selected on the basis of not having evidence of left ventricular hypertrophy, left ventricular contraction abnormality, or coronary collateralization. Studies with less rigorously selected patient groups might be expected to have an even greater range of flow reserve values for a given degree of stenosis. The similar correlation coefficients between flow reserve and the three indexes of stenosis severity in the more recent Iowa study raise the possibility that, even in highly selected groups, the diffuseness and variability of coronary disease overrides theoretical advantages of any one of these indexes in assessing the clinical impact of individual lesions. The more recent Iowa study is taken to represent "state of the art" measurements in carefully selected patients by an experienced group; its findings seem unlikely to be improved upon in the near future.
Digital-subtraction planar angiography. In this approach radiographic contrast agent is power-injected into a coronary artery at a rate that is presumed to be sufficiently rapid to achieve complete replacement of blood with contrast. It is further presumed that the iodine bolus remains undiluted (despite subsequent systolic contraction) until a peak concentration has been recorded in a downstream area of myocardial vasculature. Regional flow reserve is calculated with digitalsubtraction measurements of downstream appearance time and maximum contrast concentration before and during vasodilation. Originally introduced by Hodgson et al. at Ann Arbor,'3 the technique has also been examined by Cusma et al.,14 who have carefully summarized the derivation of the underlying flow model and the several potential problems in its application.
Since this technique's fundamental assumptions seem unlikely to be met under most clinical conditions, validation studies are of special interest. Hodgson et al. 13 administered 3 ml of contrast at a rate of 3 ml/sec through a No. 7F Amplatz coronary catheter in 14 open-chest dogs and compared contrast density/appearance time ratios with flow reserve measured by electromagnetic flowmeter. The two variables correlated with a coefficient of .92 and a regression line slope of 0.9. However, 95% confidence limits for individual measurements were relatively wide, e.g., at an electromagnetic flow reserve of 2.0, the 95% confidence limits for contrast density/appearance time ratios extended from -1. figure 8B ). With the use of injection rates of either 6 or 10 ml/sec (for 0.5 sec), image flow ratios and electromagnetic values of flow reserve correlated with a coefficient of .90 and a regression line slope of 0.96. Although confidence limits were not presented, approximately two of three data points appear to have fallen within + 25% of the line of identity, and at least nine of 10 within + 33% (see figure 8A, ref. 14) . In human studies, contrast injections have varied in rate and duration, with rates sometimes being judged as adequate when backflow into the aorta was observed.
Because of the methodologic issues and data scatter in these limited animal validation studies, clinical application of the digital-subtraction angiographic technique seems more tenuous than is the case for the Doppler probe.
Three-dimensional imaging and radionuclide techniques.
Several laboratories are now investigating the usefulness of ultrafast computed tomography, dynamic spatial reconstruction, nuclear magnetic resonance imaging, and positron-emission tomography for quantifying flow reserve in selected areas of the left ventricle. The three-dimensional approaches have the advantage over planar imaging of avoiding possible errors related to superimposition of overlying areas of the ventricle. In the first two of these techniques, flow reserve estimates are based on indicator-dilution approaches using a radiographic contrast agent. Specific procedures and analytic approaches vary and seem to be evolving rapidly as a variety of problems are identified and addressed. At the time of this writing, comparative studies of these techniques vs the radioactive microsphere technique or some other reference standard are just beginning to appear.
The positron-emission tomographic technique has a unique attraction in terms of noninvasiveness. In addition, the 82Rb used in positron-emission measurements is now amenable to on-site generator production. Quantitative methods of measurement of flow reserve in man with the use of 82Rb are still undergoing development. However, Gould et al. 15 have evaluated 82Rb perfusion images against a formula for assessing the flow reserve impairment expected from a stenosis on the basis of arteriographic measurements of its dimensions. Flow reserve calculated by the formula has been compared with flow reserve measured with a cuff-type Doppler velocity probe in normal dogs. 16 At a Doppler flow reserve of 3.0, 95% confidence limits for formulapredicted values extended from -2.4 to 3.8 (see figure  3, ref. 16 ). The formula does not, in either animal or human studies, take into account factors other than the stenosis that can affect flow reserve. It could potentially be useful for assessing the contribution of a stenosis vs other factors to a measured reduction in flow reserve.
Summary. Although measurements of flow reserve will continue to contribute importantly to our understanding of coronary pathophysiology, their role in individual patient care decisions is, at least in my viewpoint, not yet clear. The measurement of flow reserve remains conceptually attractive, not only in terms of assessing stenoses of different severity, but also in defining combined effects of a stenosis and alterations in the distal bed that the stenotic artery supplies. However, individual values of flow reserve need to be evaluated with regard to the methodologic adequacy and expected measurement scatter of the technique used. In addition, effects of a stenosis need to be separated from effects of other variables affecting flow reserve. The latter include hemodynamic variables at the time of the measurement as well as chronic changes related to factors such as ventricular hypertrophy, myocardial infarction, and collateral flow. There is question as to whether the same quantity of flow reserve that can be recruited pharmacologically can be recruited during ischemia. Individual values of flow reserve must always be considered in relation to the total clinical setting, particularly when they appear discordant with findings of other tests that have established prognostic value or that provide evidence of ischemia (as opposed to flow limitation).
The ultimate impact of these complicating factors on the clinical utility of flow reserve measurements is difficult to anticipate, particularly since clinical experience is limited and short term. Experience with other indexes of proven clinical value, e.g., ejection fraction, serves as a reminder that limitations of a measurement that initially seem major can prove minor from a practical point of view as experience is accumulated. The point to be emphasized at present is that the complexities of performance and interpretation of measurements of flow reserve are greater than generally appreciated. In my view, the measurements are still in the early stage of clinical application, and substantial additional experience is needed to define specific situations in which they can be relied upon for patient care decisions.
